Search research articles
Contact Us
Filters
Showing results (171-180 of 184) with videos related to
Page
of 19
Sort By:
ACS Medicinal Chemistry Letters
|
August 20, 2025
Discovery of Small-Molecule Ligands for the E3 Ligase STUB1/CHIP from a DNA-Encoded Library Screen
Simon C C Lucas, Alexander G Milbradt, Jason Breed, et al.
The Lancet. Respiratory Medicine
|
October 21, 2015
Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation
Claire M Midgley, John T Watson, W Allan Nix, et al.
Communications Biology
|
May 13, 2024
Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC
Thomas G Hayhow, Beth Williamson, Mandy Lawson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 5, 2018
Non-mumps Viral Parotitis During the 2014-2015 Influenza Season in the United States
Lina I Elbadawi, Pamela Talley, Melissa A Rolfes, et al.
Journal of Medicinal Chemistry
|
February 6, 2020
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS<sup>G12C</sup>
Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Journal of Medicinal Chemistry
|
April 26, 2022
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRAS<sup>G12C</sup>
Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Journal of Medicinal Chemistry
|
September 3, 2021
Optimization of an Imidazo[1,2-<i>a</i>]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with <i>In Vivo</i> Efficacy
William McCoull, Scott Boyd, Martin R Brown, et al.
Contemporary Clinical Trials
|
March 7, 2019
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease
Samantha C Roberts, Sonia Jain, Adriana H Tremoulet, et al.
Journal of Medicinal Chemistry
|
July 3, 2023
Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRAS<sup>G12C</sup> with Demonstrable CNS Penetration
Jason G Kettle, Sharan K Bagal, Derek Barratt, et al.
Journal of Medicinal Chemistry
|
September 3, 2025
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome
Avipsa Ghosh, Afshan Ahmed, Konstantina Amoiradaki, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 184) with videos related to
Sort By:
Page
of 19
ACS Medicinal Chemistry Letters
|
August 20, 2025
Discovery of Small-Molecule Ligands for the E3 Ligase STUB1/CHIP from a DNA-Encoded Library Screen
Simon C C Lucas, Alexander G Milbradt, Jason Breed, et al.
The Lancet. Respiratory Medicine
|
October 21, 2015
Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation
Claire M Midgley, John T Watson, W Allan Nix, et al.
Communications Biology
|
May 13, 2024
Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC
Thomas G Hayhow, Beth Williamson, Mandy Lawson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 5, 2018
Non-mumps Viral Parotitis During the 2014-2015 Influenza Season in the United States
Lina I Elbadawi, Pamela Talley, Melissa A Rolfes, et al.
Journal of Medicinal Chemistry
|
February 6, 2020
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS<sup>G12C</sup>
Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Journal of Medicinal Chemistry
|
April 26, 2022
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRAS<sup>G12C</sup>
Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Journal of Medicinal Chemistry
|
September 3, 2021
Optimization of an Imidazo[1,2-<i>a</i>]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with <i>In Vivo</i> Efficacy
William McCoull, Scott Boyd, Martin R Brown, et al.
Contemporary Clinical Trials
|
March 7, 2019
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease
Samantha C Roberts, Sonia Jain, Adriana H Tremoulet, et al.
Journal of Medicinal Chemistry
|
July 3, 2023
Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRAS<sup>G12C</sup> with Demonstrable CNS Penetration
Jason G Kettle, Sharan K Bagal, Derek Barratt, et al.
Journal of Medicinal Chemistry
|
September 3, 2025
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome
Avipsa Ghosh, Afshan Ahmed, Konstantina Amoiradaki, et al.
Page
of 19